Evaluation of the Severity of Hyperlipidemia Pancreatitis Using CT-measured Visceral Adipose Tissue. Issue 7 (August 2019)

• Record Type: Journal Article
• Authors: Ji, Ting; Li, Xueliang; Zhang, Xiangcheng; Hui, Liangliang; Shang, Futai; Zhu, Xingxing; Guo, Lili; Xu, Yiming
• Is Part Of: Journal of clinical gastroenterology. Volume 53:Issue 7(2019)
• Publication Date: 2019-08
• Subjects: VAT -- visceral adipose tissue -- HLAP -- hyperlipidemia acute pancreatitis; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Digestive organs -- Diseases; Gastroenterology; Periodicals; Periodicals; 616.33005
• DOI: 10.1097/MCG.0000000000001079
• Languages: English
• ISSNs: 0192-0790

Abstract

Abstract : Background: Computed tomography–measured visceral adipose tissue (VAT) and the distribution of VAT are highly correlated with the severity and prognosis of acute pancreatitis (AP). To date, all available data are from the overall AP patient population; no subgroup analysis has been conducted to evaluate patients with moderately severe AP or patients with hyperlipidemia acute pancreatitis (HLAP) as independent populations. Currently, studies on the relationship between VAT and HLAP are lacking. Materials and Methods: A total of 235 patients with moderately severe AP or severe acute pancreatitis were divided into 2 groups according to whether hyperlipidemia was present: the HLAP group and the non-HLAP group. The general inpatient information was collected, and computed tomography was used to measure VAT, subcutaneous adipose tissue (SAT), total adipose tissue, and VAT/SAT (V/S). The data were subjected to t test, χ 2 test, matrix scatter plot, logistic regression, and receiver operating characteristic analyses to evaluate the relationship between VAT and HLAP severity. Results: Significant differences were observed in VAT, SAT, total adipose tissue, and triglycerides (TGs) between the HLAP group and the non-HLAP group ( P <0.001). Significant correlations were observed between VAT and body mass index ( r =0.425, P =0.017) and between VAT and TG ( r =0.367, P =0.042). In the HLAP group, VAT, V/S, TG, and local complications may have significant effects on disease severity. The receiver operating characteristic curves showed that VAT and V/S were more reliable than TGs in evaluating disease severity [area under the curve (AUC) of VAT: 0.819, P <0.001; AUC of V/S: 0.855, P <0.001; AUC of TG: 0.671, P =0.04]. Disease severity was reliably evaluated at 139 cm 2, the cut-off value of VAT. The cut-off value of V/S was 1.145; high V/S was associated with extended intensive care unit stay. VAT and its distribution had no significant effects on mortality. Conclusions: For patients with moderately severe to severe HLAP, VAT was correlated with body mass index and TG. VAT and V/S were valuable factors for evaluating disease severity and prognosis. However, VAT had no effect on mortality, and VAT could not be used to evaluate patients with moderately severe to severe non-HLAP. Abstract : Supplemental Digital Content is available in the text.